Boulder Care, a telehealth provider specializing in substance use disorder treatment, has received a $1.8 million grant from the National Institutes of Health (NIH). The funding, awarded by the National Institute on Drug Abuse, aims to improve access to addiction treatment for patients in complex or difficult to reach settings. This initiative highlights growing efforts to leverage telehealth in addressing gaps in behavioral health care, particularly for vulnerable populations.
Latest Developments
Boulder Care, a telehealth provider focused on substance use disorder treatment, has secured $1.8 million in funding from the National Institutes of Health (NIH). The grant, awarded by the National Institute on Drug Abuse (NIDA), will support efforts to expand access to addiction treatment for patients in underserved or hard to reach settings. This includes rural communities, correctional facilities, and other environments where traditional in person care may be limited or unavailable.
Why This Matters
Substance use disorders remain a critical public health challenge, with nearly 49 million Americans affected in 2022, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). Despite the high demand for treatment, barriers such as geographic isolation, stigma, and limited local resources often prevent patients from receiving care. Telehealth has emerged as a promising solution, particularly during the COVID 19 pandemic, when regulatory flexibilities allowed broader adoption of virtual care for addiction treatment.
The NIH funding underscores the federal government's recognition of telehealth as a viable tool for expanding treatment access. Boulder Care's initiative aligns with broader efforts to integrate digital health solutions into behavioral health care, particularly for populations that have historically faced systemic barriers to treatment. The grant will also support research into the effectiveness of telehealth models in these settings, potentially informing future policy and clinical practices.
Public Health Impact
The $1.8 million grant arrives at a time when overdose deaths in the U.S. have reached record levels, with over 110,000 fatalities reported in 2022 alone, per CDC data. Opioids, including fentanyl, continue to drive the crisis, accounting for nearly 75% of all drug overdose deaths. Telehealth has shown promise in reducing these numbers by improving access to medications for opioid use disorder (MOUD), such as buprenorphine, which can significantly lower the risk of overdose.
Boulder Care's focus on complex settings, such as correctional facilities, where substance use disorders are prevalent but treatment options are often scarce, could serve as a model for other providers. The company currently operates in 11 states, offering virtual care for opioid, alcohol, and stimulant use disorders. The NIH funding will enable the expansion of these services, with a particular emphasis on evidence based treatments and patient centered care.
Expert Perspective
Dr. Nora Volkow, director of NIDA, emphasized the importance of innovative approaches in addressing the addiction crisis. "Telehealth has the potential to break down longstanding barriers to treatment, particularly for individuals in rural or underserved areas," she said. "This funding will help us better understand how digital health tools can be leveraged to improve outcomes and save lives."
Experts also note that while telehealth has expanded access, challenges remain, including digital literacy, internet connectivity, and reimbursement policies. The NIH grant will support research to address these gaps, ensuring that telehealth solutions are both effective and equitable.
What's Next
Boulder Care plans to use the NIH funding to pilot its telehealth model in new settings, including correctional facilities and rural clinics. The company will also collaborate with researchers to evaluate the program's impact on patient outcomes, such as treatment retention and overdose rates. Findings from the initiative could inform future federal and state policies on telehealth reimbursement and addiction treatment access.
In a separate development, Overstory Health, a digital health startup focused on behavioral health analytics, announced a $1.4 million seed funding round. While not directly related to Boulder Care's grant, the funding highlights the growing investment in technology driven solutions for behavioral health care.
Key Takeaways
- Boulder Care received a $1.8 million NIH grant to expand telehealth addiction treatment for underserved populations, including rural and correctional settings.
- The funding reflects federal recognition of telehealth as a critical tool in addressing the U.S. overdose crisis, which claimed over 110,000 lives in 2022.
- The initiative will support research into telehealth's effectiveness in complex settings, potentially shaping future policies and clinical practices.
Frequently Asked Questions
What is Boulder Care?
Boulder Care is a telehealth provider specializing in evidence based treatment for substance use disorders, including opioid, alcohol, and stimulant use disorders.
How will the NIH funding be used?
The $1.8 million grant will expand telehealth services to hard to reach settings, such as rural communities and correctional facilities, and support research into the program's effectiveness.
Why is telehealth important for addiction treatment?
Telehealth improves access to care for patients who face barriers like geographic isolation, stigma, or limited local resources, and has been shown to increase treatment retention and reduce overdose risks.
Published by O. Ayodeji | Review by MedSense Editorial Board
DISCUSSION (0)
POST A COMMENT